Zynex Inc (NASDAQ:ZYXI) — Market Cap & Net Worth
Market Cap & Net Worth: Zynex Inc (ZYXI)
Zynex Inc (NASDAQ:ZYXI) has a market capitalization of $2.61 Million ($2.61 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29383 globally and #5745 in its home market, demonstrating a 115.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zynex Inc's stock price $0.09 by its total outstanding shares 30388635 (30.39 Million). Analyse cash flow conversion of Zynex Inc to see how efficiently the company converts income to cash.
Zynex Inc Market Cap History: 2015 to 2026
Zynex Inc's market capitalization history from 2015 to 2026. Data shows change from $12.07 Million to $2.61 Million (-4.89% CAGR).
Index Memberships
Zynex Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #877 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2790 of 3165 |
Weight: Zynex Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Zynex Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zynex Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.27x
Zynex Inc's market cap is 1.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
81.30x
Zynex Inc's market cap is 81.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.07 Million | $11.64 Million | -$2.91 Million | 1.04x | N/A |
| 2016 | $7.99 Million | $13.31 Million | $69.00K | 0.60x | 115.79x |
| 2017 | $84.70 Million | $23.43 Million | $7.37 Million | 3.61x | 11.50x |
| 2018 | $80.41 Million | $31.92 Million | $9.55 Million | 2.52x | 8.42x |
| 2019 | $215.25 Million | $45.47 Million | $9.49 Million | 4.73x | 22.68x |
| 2020 | $368.14 Million | $80.12 Million | $9.07 Million | 4.59x | 40.57x |
| 2021 | $272.69 Million | $130.30 Million | $17.10 Million | 2.09x | 15.94x |
| 2022 | $422.71 Million | $158.17 Million | $17.05 Million | 2.67x | 24.80x |
| 2023 | $330.93 Million | $184.32 Million | $9.73 Million | 1.80x | 34.00x |
| 2024 | $243.41 Million | $192.35 Million | $2.99 Million | 1.27x | 81.30x |
Competitor Companies of ZYXI by Market Capitalization
Companies near Zynex Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Zynex Inc by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
Zynex Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Zynex Inc's market cap moved from $12.07 Million to $ 2.61 Million, with a yearly change of -4.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.61 Million | -36.30% |
| 2025 | $4.10 Million | -98.31% |
| 2024 | $243.41 Million | -26.45% |
| 2023 | $330.93 Million | -21.71% |
| 2022 | $422.71 Million | +55.02% |
| 2021 | $272.69 Million | -25.93% |
| 2020 | $368.14 Million | +71.03% |
| 2019 | $215.25 Million | +167.68% |
| 2018 | $80.41 Million | -5.06% |
| 2017 | $84.70 Million | +960.17% |
| 2016 | $7.99 Million | -33.80% |
| 2015 | $12.07 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Zynex Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.61 Million USD |
| MoneyControl | $2.61 Million USD |
| MarketWatch | $2.61 Million USD |
| marketcap.company | $2.61 Million USD |
| Reuters | $2.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more